JONATHAN W. AYERS - 18 Feb 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
Issuer symbol
IDXX
Transactions as of
18 Feb 2022
Transactions value $
$99,970
Form type
4
Filing time
22 Feb 2022, 16:00:40 UTC
Previous filing
17 Feb 2022
Next filing
13 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $100K +706 +0.11% $141.60 630K 18 Feb 2022 Direct
holding IDXX Common Stock 10K 18 Feb 2022 by Ayers Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -706 -100% 0 18 Feb 2022 Common Stock 706 $141.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy 706 shares of IDEXX Laboratories, Inc. common stock that became exercisable in one installment on February 14, 2022.
F2 Not applicable.